Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Asset Writedowns and Impairment (2023 - 2025)

Allogene Therapeutics (ALLO) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $18000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 205.88% to $18000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 90.55% year-over-year, with the annual reading at $2.4 million for FY2025, 84.71% down from the prior year.
  • Asset Writedowns and Impairment hit $18000.0 in Q4 2025 for Allogene Therapeutics, down from $2.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $10.7 million in Q3 2024 to a low of -$17000.0 in Q4 2024.
  • Historically, Asset Writedowns and Impairment has averaged $4.6 million across 3 years, with a median of $3.7 million in 2024.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 100.18% in 2024 and later skyrocketed 205.88% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $9.5 million in 2023, then tumbled by 100.18% to -$17000.0 in 2024, then surged by 205.88% to $18000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for ALLO at $18000.0 in Q4 2025, $2.4 million in Q2 2025, and -$17000.0 in Q4 2024.